Opus Genetics Announces FDA Clearance of IND Application for Gene Therapy Candidate OPGx-BEST1

Monday, August 18, 2025 1 min read

Key Takeaway: Opus Genetics Announces FDA Clearance of IND Application for Gene Therapy Candidate OPGx-BEST1

Full Press Release Details

Opus Genetics Announces FDA Clearance of IND Application for Gene Therapy Candidate OPGx-BEST1.